logo

For the Inventor, By the Inventor

Hillsborough, CA, United States of America

Warner C Greene

USPTO Granted Patents = 15 


Average Co-Inventor Count = 3.5

ph-index = 1

Forward Citations = 13(Granted Patents)


Location History:

  • South San Francisco, CA (US) (2022)
  • Hillsborough, CA (US) (2001 - 2023)
  • San Francisco, CA (US) (2003 - 2024)

Company Filing History:

goldMedal9 out of 90 
 
The J. David Gladstone Institutes
 patents
silverMedal4 out of 15,475 
 
University of California
 patents
bronzeMedal2 out of 19 
 
The J. David Gladstone Institutes, a Testamentary Trust Established Under the Will of J. David Gladstone
 patents
4. 1 out of 6 
 
Xyphos Biosciences Inc.
 patents
where one patent can have more than one assignee

Years Active: 2001-2024

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 12016934 - Animal model for SARS-CoV-2-spike induced coagulopathy (2024-06-25),
2. 11590110 - Compositions and methods for reactivating latent immunodeficiency virus using a GSK-3 inhibitor (2023-02-28),
3. 11440948 - Modified non-natural NKG2D ligands that selectively deliver attached heterologous molecules to non-natural NKG2D receptors on car-cells (2022-09-13),
4. 9956260 - Treatment of HIV-1 infection and AIDS (2018-05-01),
5. 9352010 - Treatment of HIV-1 infection and AIDS (2016-05-31),
6. 8338180 - Methods for treating lentivirus infections (2012-12-25),
7. 8247613 - Methods and compositions for the synergistic activation of latent HIV (2012-08-21),
8. 7723021 - Methods for treating lentivirus infections (2010-05-25),
9. 7250251 - Virion-based fusion assay (2007-07-31),
10. 7108988 - Methods of identifying agents for inhibiting lentivirus replication (2006-09-19),
11. 7081343 - Methods for identifying modulators of NF-KB activity (2006-07-25),
12. 6664040 - Compositions and methods for delivery of a molecule into a cell (2003-12-16),
13. 6645728 - Inhibitor of the inflammatory response induced by TNF&agr; and IL-1 (2003-11-11),
14. 6265538 - Inhibitor of the inflammatory response induced by the TNFA and IL-1 (2001-07-24),
15. 6180772 - Nucleic acids encoding dominant negative I-&kgr;-B -&agr; polypeptides (2001-01-30),

Title: Warner C Greene: Innovator in Medical Research

Introduction

Warner C Greene is a prominent inventor based in Hillsborough, CA, known for his significant contributions to medical research. He holds a total of 15 patents, showcasing his innovative approach to addressing critical health issues.

Latest Patents

One of his latest patents is an animal model for SARS-CoV-2-spike induced coagulopathy. This model is designed to identify therapeutic agents that can mitigate the physiological effects of COVID-19 infection, including inflammation, oxidative stress, fibrin deposition, blood-brain barrier breakdown, clotting, and vascular problems. Another notable patent involves compositions and methods for reactivating latent immunodeficiency virus using a GSK-3 inhibitor. This patent outlines the use of glycogen synthase kinase 3 inhibitors, such as Tideglusib and SB-216763, to reactivate latent immunodeficiency virus.

Career Highlights

Warner C Greene has worked with esteemed institutions, including the J. David Gladstone Institutes and the University of California. His work has significantly advanced the understanding of viral infections and their treatment.

Collaborations

Throughout his career, Greene has collaborated with notable colleagues, including Michael P Sherman and Ulrich Schubert. These partnerships have further enriched his research and innovation efforts.

Conclusion

Warner C Greene's contributions to medical research through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to impact the development of therapeutic solutions for critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…